Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Wright Medical Group Inc Reaffirms FY 2012 Revenue Guidance; Raises FY 2012 EPS Guidance


Monday, 5 Nov 2012 04:00pm EST 

Wright Medical Group Inc announced that continues to anticipate fiscal 2012 net sales to be in the range of $476 million to $485 million and has increased its as-adjusted earnings per share excluding stock-based compensation guidance to be in the range of $0.34 to $0.40 per diluted share (EPS) from the previously communicated range of $0.32 to $0.36. As noted above, the Company's earnings target excludes the impact of non-cash stock-based compensation charges. While the amount of the non-cash stock-based compensation charges will vary depending upon a number of factors, the Company currently estimates that the after-tax impact of those expenses will be approximately $0.18 per diluted share for the full year 2012. Therefore, the Company now anticipates its fiscal 2012 as-adjusted earnings per share including stock-based compensation to be in the range of $0.16 to $0.22 per diluted share. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $484 million for fiscal 2012. 

Company Quote

30.82
-0.63 -2.00%
4:00pm EDT